Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal Atropine vs Metoclopramide for IONV in C-Section
NCT03932578Phase 4Completed
- Sponsor
- Mansoura University
- Start
- May 2019
- Primary completion
- Aug 2019
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of atropine in nausea ((none)) and Vomiting (2 arms), sponsored by Mansoura University. Primary endpoints: Intraoperative Nausea and Vomiting and Postoperative Nausea and Vomiting. Started May 2019; status: completed.
02
Drugs
atropine
03
Conditions
nausea ((none))Vomiting
Beyond the preview
Go deeper on NCT03932578.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03932578.